Articles
Harnessing the Power of AI to Detect ATTR-CM
Artificial intelligence (AI) has quietly become a part of our daily lives – through personalized recommendations, virtual assistants, or smart devices, we barely notice it anymore. Yet many of us might not realize the advances AI is making in healthcare. From accelerating drug discovery to improving disease detection, it is transforming the way we understand and manage health.AI has had numerous applications in cardiology in recent years, from analyzing results of cardiac imaging tests to....
In Search of a New Hemophilia Treatment
Despite significant advancements in hemophilia treatments over the past several decades, a fundamental challenge remains for many patients: balancing management of the disorder while maintaining regular day-to-day activities.Historically, treatments could be cumbersome and time-consuming to administer. They typically required intravenous administration up to several times a week to prevent bleeding episodes.1 Even treatments that could be administered at home required infusions multiple times a....
Viral vs Bacterial Infections: Different Pathogens, Different Approaches
When you experience symptoms of an infection such as fever, fatigue, decreased appetite, or pain, knowing whether a virus or bacteria is making you sick may be the key to getting the right treatment and feeling better.1,2Viruses and bacteria are among the most well-known causes of infection.3 Infections occur when viruses or bacteria invade the human host and proliferate.3 But there are some important distinctions between them, and it’s important to determine whether it’s a bacteria or virus....
Pharma Peers Unite to Build DNA-Encoded Libraries
Finding tools and hits for targets in drug discovery can feel like hunting for four leaf clovers in a blizzard. And researcher Sylvie Sakata was close to giving up on one discovery tool, DNA-encoded libraries, when a new consortium started to fall into place. Now this technology is garnering more interest for its potential to discover new molecular compounds, known as “hits,” to exponentially impact the early research efforts that can lead to potential new medicines.Sakata is the Head of....
What You Need to Know About a Promising Vaccine Candidate that May Stem the Growing Risk of Lyme Disease
Lyme disease is the most common vector-borne illness in the United States.1 The U.S. Centers for Disease Control and Prevention (CDC) says that state health departments reported over 63,000 cases in 2022.2 However, the CDC uses other methods to estimate that approximately 476,000 people in the U.S. may be diagnosed and treated for Lyme disease annually.2In other words, the estimated number of Lyme disease cases in the U.S. seems to be much higher than what is being reported to public health....
Caregiver Support: A Guide to Self-Care for Caregivers
A mother helps her daughter through dialysis at night and goes to work without sleep.1 A wife cares for her husband as he spends 110 days recovering from treatment for acute myeloid leukemia in a hospital 250 miles from home.2 A son quits his job to support his mother after she suffers a series of strokes.3Each caregiver’s story is different, but their combined efforts serve as a lifeline to millions of people. Caregivers support children, parents, grandparents, family members, spouses....
A New Road to Migraine Relief
Migraine, a debilitating neurological disorder,1 affects over a billion people globally.2,3 The cause of migraine remains an active area of research–experts believe genetics, the nervous system, and the brain's blood vessels are involved in the condition.4,5 The majority of people have episodic migraine, experiencing between 0-14 days of headache per month.6 On the other hand, those with chronic migraine experience 15 or more days of headaches a month, with at least 8 of those days caused by....
Global Health Fellows: Partnering to Strengthen Health Systems
Recently, Ellen Gerstein, Pfizer's Senior Director of Digital Communications, visited Africa as part of our Global Fellows Program. She shares her experience in this article.At Pfizer, we’re driven by our Purpose—to deliver breakthroughs that change patients’ lives. That Purpose has never been more clear to me than during my experience partnering with North Star Alliance through Global Health Fellows—Pfizer’s signature skills-based volunteering program.Since 2003, Global Health Fellows has....
Clinical Trial Innovation: Putting the Patient First in Clinical Trial Design
Every day, across the United States and around the world, scientists are developing potential new medicines and vaccines that could change lives. But to get medicines and vaccines to the patients who need them most, they must first undergo a clinical trial, which is a research study that seeks to understand how potential medicines and other medical treatments work.These studies depend on the generosity of participants, who volunteer to be a part of the trial. Depending on the type of trial....
Behind the Science Features
Understanding Obesity as a Complex Disease
Some people think obesity is simply caused by unhealthy eating habits and not exercising enough. But, in fact, the scientific and medical community defines obesity as a complex, multifactoral chronic disease.
Gene Therapy Myth Busting Quiz
Pfizer experts discuss some of the myths that persist about how gene therapy treatments work and what they can potentially do. Can you separate fact from fiction?
Understanding Pfizer’s Product Pipeline
Pfizer’s product pipeline is a summary of the investigational medicines and vaccines that we’re currently researching and testing, but it can mean so much more. Here’s what it is and why you should care.
Subscriptions
Sign up for communications from Pfizer
Receive the latest news from Pfizer in our monthly The Breakthrough newsletter and email alerts on a variety of topics.
Sign Up Now Details
Newsroom
The latest media resources from Pfizer
Working journalist? Visit the Pfizer Newsroom for our complete library of news, announcements and multimedia assets.
Read More Details